SCHEMBL7786952

SCHEMBL7786952

COc1ccc2c(c1)-c1cc(OC)ccc1C2=NO

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.85
MEN1 O00255 5/20 0.85
MAPT P10636 4/20 0.85
ALDH1A1 P00352 2/20 0.85
APP P05067 1/20 0.85
SNCA P37840 1/20 0.85
CYP1A2 P05177 3/20 0.55
CYP2D6 P10635 3/20 0.55
CYP2C9 P11712 3/20 0.55
CYP2C19 P33261 3/20 0.55
NPSR1 Q6W5P4 2/20 0.55
CYP3A4 P08684 2/20 0.55
HPGD P15428 1/20 0.55
RAB9A P51151 1/20 0.55
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA7 P43166 3/20 0.47
CA9 Q16790 3/20 0.47
CA4 P22748 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7789346 0.81 MEN1 (0.57) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL7789347 0.81 MEN1 (0.57) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL1134724 0.79 ALDH1A1 (0.64) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL346790 0.79 ALDH1A1 (0.64) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL22867709 0.75 GPR3 (0.50) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL31669020 0.73 GPR3 (0.59) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL25693544 0.73 GPR3 (0.59) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL7786812 0.71 CA1 (0.57) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL28155812 0.71 CA1 (0.57) KMT2AMEN1MAPTALDH1A1APP
SCHEMBL6565651 0.71 ALDH1A1 (0.54) KMT2AMEN1MAPTALDH1A1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1088855-C Oximesulfonic acid esters and use thereof as latent sulfonic acids CIBA SC HOLDING AG (CH) 2002-08-07 CN disclosed
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 US disclosed
CN-1153926-A Oximesulfonic acid esters and use thereof as latent sulfonic acids CIBA GEIGY AG (CH) 1997-07-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH KMT2A 2207/4885MEN1 4038/4885MAPT 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.